Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:130-135
Published online before print October 10, 2002, doi: 10.1161/01.ATV.0000041037.06509.C2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/1/130    most recent
01.ATV.0000041037.06509.C2v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gulledge, A. A.
Right arrow Articles by Lord, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gulledge, A. A.
Right arrow Articles by Lord, S. T.
Related Collections
Right arrow Other Ethics and Policy
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Clinical Studies
Right arrow CV surgery: aortic and vascular disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:130.)
© 2003 American Heart Association, Inc.


Thrombosis

Effects of Hyperfibrinogenemia on Vasculature of C57BL/6 Mice With and Without Atherogenic Diet

Alyssa A. Gulledge; Cynthia McShea; Todd Schwartz; Gary Koch; Susan T. Lord

From the Curriculum in Genetics and Molecular Biology (A.A.G., S.T.L.), the Department of Biostatistics (C.M., T.S., G.K.), and the Department of Pathology and Laboratory Medicine (S.T.L.), University of North Carolina, Chapel Hill.

Correspondence to Susan T. Lord, Department of Pathology, UNC-CH, CB# 7525, BBB 603, Chapel Hill, NC 27599-7525. E-mail stl{at}med.unc.edu

Objective— Elevated fibrinogen is correlated with severe atherosclerosis, as defined by the occurrence of ischemic events, but the mechanistic basis for this correlation remains unknown. To study this relationship, we examined spontaneous and diet-induced atherosclerosis in transgenic mice with hyperfibrinogenemia (elevated fibrinogen).

Methods and Results— Normal and transgenic mice were fed either an atherogenic diet or simple breeder chow. We measured plasma fibrinogen levels and identified an age-dependent and diet-dependent increase in fibrinogen. After 8 to 12 months, aortic sections were prepared and stained, and lipid-containing lesions were counted, measured, and assessed for maturity. Lipid-filled deposits appeared spontaneously in a small number of mice on breeder chow; typical fatty streak-type lesions appeared in almost all of the diet-fed animals. Morphometric analysis showed that neither the number nor the size of lesions was influenced by either fibrinogen level or genotype.

Conclusions— Our data showed that neither fibrinogen concentration nor genotype had a statistically significant effect on the initiation, initial growth, or early progression of atherosclerotic lesions.


Key Words: fibrinogen • atherosclerosis • mouse model • hyperfibrinogenemia • atherogenic diet




This article has been cited by other articles:


Home page
CirculationHome page
S. Seehaus, K. Shahzad, M. Kashif, I. A. Vinnikov, M. Schiller, H. Wang, T. Madhusudhan, V. Eckstein, A. Bierhaus, F. Bea, et al.
Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1-, Phospholipase-C{beta}-, Phosphoinositide 3-Kinase-, and Nitric Oxide-Dependent Signaling in Monocytes and Promotes Plaque Stability
Circulation, September 1, 2009; 120(9): 774 - 784.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
P. Welsh, P.H. Whincup, O. Papacosta, S.G. Wannamethee, L. Lennon, A. Thomson, A. Rumley, and G.D.O. Lowe
Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men
QJM, October 1, 2008; 101(10): 785 - 791.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. P. Fay
Hyperfibrinogenemia and vascular disease: does it matter?
Blood, March 1, 2004; 103(5): 1569 - 1570.
[Full Text] [PDF]


Home page
BloodHome page
B. Kerlin, B. C. Cooley, B. H. Isermann, I. Hernandez, R. Sood, M. Zogg, S. B. Hendrickson, M. W. Mosesson, S. Lord, and H. Weiler
Cause-effect relation between hyperfibrinogenemia and vascular disease
Blood, March 1, 2004; 103(5): 1728 - 1734.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
W. H Reinhart
Fibrinogen - marker or mediator of vascular disease?
Vascular Medicine, August 1, 2003; 8(3): 211 - 216.
[Abstract] [PDF]